Lupin Limited has informed the Exchange regarding a press release dated January 16, 2023, titled “Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir and RilpivirineTablets.”…….
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
